# Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

> **NCT00002753** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 6 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **RADIATION:** iodine I 131 monoclonal antibody 81C6

## Key facts

- **NCT ID:** NCT00002753
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-11
- **Primary completion:** 2001-04
- **Final completion:** 2001-04
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2013-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002753, "Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00002753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*